ATTENTIVE PHARMA LIMITED

Company number 10871719

Date	Type	Description	View / Download
30 Apr 2024	LIQ03	Liquidators' statement of receipts and payments to 1 March 2024	(9 pages)
24 Apr 2023	LIQ03	Liquidators' statement of receipts and payments to 1 March 2023	(8 pages)
04 May 2022	LIQ03	Liquidators' statement of receipts and payments to 1 March 2022	(10 pages)
25 Aug 2021	AA	Total exemption full accounts made up to 31 December 2020	(6 pages) Download iXBRL
25 Aug 2021	CS01	Confirmation statement made on 11 July 2021 with no updates	(3 pages)
25 Mar 2021	LIQ01	Declaration of solvency	(5 pages)
25 Mar 2021	600	Appointment of a voluntary liquidator	(3 pages)
25 Mar 2021	RESOLUTIONS	Resolutions LRESSP ‐ Special resolution to wind up on 2021-03-02	(1 page)
22 Mar 2021	AD01	Registered office address changed from 102 High Street Godalming Surrey GU7 1DS United Kingdom to 6th Floor 2 London Wall Place London EC2Y 5AU on 22 March 2021	(2 pages)
02 Sep 2020	AA	Accounts for a small company made up to 31 December 2019	(9 pages) Download iXBRL
13 Jul 2020	CS01	Confirmation statement made on 11 July 2020 with updates	(4 pages)
23 Jun 2020	AP03	Appointment of Mr Gary David Buckley as a secretary on 15 June 2020	(2 pages)
23 Jun 2020	AP01	Appointment of Mr Gary David Buckley as a director on 15 June 2020	(2 pages)
05 Jun 2020	TM01	Termination of appointment of Debra Joy Roberts as a director on 31 May 2020	(1 page)
18 Sep 2019	PSC07	Cessation of Aspire Pharma Holdings Limited as a person with significant control on 16 September 2019	(1 page)
18 Sep 2019	TM01	Termination of appointment of David Alan Rowley as a director on 16 September 2019	(1 page)
18 Sep 2019	PSC07	Cessation of Oh Investors Limited as a person with significant control on 16 September 2019	(1 page)
24 Jul 2019	TM01	Termination of appointment of Richard Baderin as a director on 17 July 2019	(1 page)
11 Jul 2019	CS01	Confirmation statement made on 11 July 2019 with no updates	(3 pages)
11 Apr 2019	AA	Accounts for a small company made up to 31 December 2018	(8 pages)
17 Jul 2018	CS01	Confirmation statement made on 17 July 2018 with updates	(4 pages)
22 Jun 2018	AP01	Appointment of Mr David Alan Rowley as a director on 28 March 2018	(2 pages)
03 May 2018	SH01	Statement of capital following an allotment of shares on 28 March 2018 GBP 100	(8 pages)
27 Apr 2018	PSC02	Notification of Aspire Pharma Holdings Limited as a person with significant control on 28 March 2018	(4 pages)
27 Apr 2018	AP01	Appointment of Debra Joy Roberts as a director on 28 March 2018	(2 pages)

• 1
• 2

Next